Spruce Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CARLYLE GROUP INC. | 02/13/2025 | 2.90 M | $1.22 M | 0.00% | 7.01% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 2.61 M | $1.10 M | 0.00% | 6.32% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 1.05 M | $437,000 | -16.94% | 2.53% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 1.00 M | $420,000 | 100.00% | 2.42% |
| VANGUARD GROUP INC | 02/11/2025 | 843,844 | $354,415 | 0.00% | 2.04% |
| SANDS CAPITAL VENTURES, LLC | 02/13/2025 | 715,817 | $300,643 | -9.05% | 1.73% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 405,900 | $170,478 | -33.43% | 0.98% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 403,716 | $169,561 | 0.00% | 0.98% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 288,800 | $121,296 | 100.00% | 0.70% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 273,785 | $115,013 | 4.52% | 0.66% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 124,734 | $52,388 | 0.00% | 0.30% |
| UBS GROUP AG | 02/14/2025 | 86,045 | $36,138 | 661,784.62% | 0.21% |
| LION POINT CAPITAL, LP | 02/14/2025 | 75,000 | $31,500 | 0.00% | 0.18% |
| STATE STREET CORP | 02/14/2025 | 60,700 | $25,494 | -5.75% | 0.15% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 58,984 | $24,773 | 100.00% | 0.14% |
| SHAY CAPITAL LLC | 02/14/2025 | 38,119 | $16,010 | 0.00% | 0.09% |
| HRT FINANCIAL LP | 02/14/2025 | 37,838 | $15,000 | 100.00% | 0.09% |
| XTX TOPCO LTD | 02/13/2025 | 35,549 | $14,931 | 85.79% | 0.09% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 34,900 | $14,658 | -12.75% | 0.08% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 20,616 | $8,659 | -11.78% | 0.05% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 13,800 | $5,796 | -49.08% | 0.03% |
| SIMPLEX TRADING, LLC | 02/11/2025 | 4,857 | $2,000 | 100.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 4,761 | $2,000 | 2.39% | 0.01% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 1,769 | $743 | -53.92% | 0.00% |
| CALDWELL SUTTER CAPITAL, INC. | 01/21/2025 | 1,000 | $420 | 0.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 181 | $76 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/12/2025 | 69 | $29 | -2.82% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ALMITAS CAPITAL LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Spruce Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 39 institutional investors and hedge funds held shares of Spruce Biosciences, Inc.. The most heavily invested institutionals were:
Carlyle Group Inc.: 2.9 M
Rock Springs Capital Management LP: 2.61 M
ACADIAN ASSET MANAGEMENT LLC: 1.05 M
Ikarian Capital, LLC: 1,000,000
VANGUARD GROUP INC: 843,844
Sands Capital Ventures, LLC: 715,817
27.03% of Spruce Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 16.12 M shares in the last 24 months. This purchase volume represents approximately $6.45 M in transactions.